Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
SWKH logo SWKH
Upturn stock ratingUpturn stock rating
SWKH logo

SWK Holdings Corp (SWKH)

Upturn stock ratingUpturn stock rating
$14.6
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/16/2025: SWKH (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $18.5

1 Year Target Price $18.5

Analysts Price Target For last 52 week
$18.5 Target price
52w Low $11.99
Current$14.6
52w High $16.23

Analysis of Past Performance

Type Stock
Historic Profit -14.96%
Avg. Invested days 50
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/16/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 177.35M USD
Price to earnings Ratio 10.35
1Y Target Price 18.5
Price to earnings Ratio 10.35
1Y Target Price 18.5
Volume (30-day avg) 1
Beta 0.2
52 Weeks Range 11.99 - 16.23
Updated Date 09/16/2025
52 Weeks Range 11.99 - 16.23
Updated Date 09/16/2025
Dividends yield (FY) -
Basic EPS (TTM) 1.41

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 46.55%
Operating Margin (TTM) 56.9%

Management Effectiveness

Return on Assets (TTM) 5.74%
Return on Equity (TTM) 6.58%

Valuation

Trailing PE 10.35
Forward PE -
Enterprise Value 201861804
Price to Sales(TTM) 4.74
Enterprise Value 201861804
Price to Sales(TTM) 4.74
Enterprise Value to Revenue 4.52
Enterprise Value to EBITDA 7.03
Shares Outstanding 12147400
Shares Floating 2318087
Shares Outstanding 12147400
Shares Floating 2318087
Percent Insiders 6.44
Percent Institutions 87.36

ai summary icon Upturn AI SWOT

SWK Holdings Corp

stock logo

Company Overview

overview logo History and Background

SWK Holdings Corp. was founded in 2010. It focuses on providing specialized financing solutions to companies in the healthcare sector. The company has grown through strategic investments and portfolio expansions in various healthcare verticals.

business area logo Core Business Areas

  • Healthcare Finance: Provides financing solutions to healthcare companies, including specialty finance, venture debt, and asset-based lending.

leadership logo Leadership and Structure

Winston Black serves as CEO. The company has a board of directors and operates with a structured management team focusing on investment and portfolio management.

Top Products and Market Share

overview logo Key Offerings

  • Specialty Finance: Offers customized financing solutions to healthcare companies. Market share data is not readily available as this is a niche market; competitors include other specialty finance firms focused on healthcare. Revenue from this product varies year to year. Competitors: Oxford Finance, Silicon Valley Bank (now part of First Citizens), Hercules Capital.

Market Dynamics

industry overview logo Industry Overview

The healthcare finance industry is driven by innovation and growth, requiring significant capital for research, development, and commercialization. Specialty finance caters to the needs of companies that may not qualify for traditional bank loans.

Positioning

SWK Holdings Corp is positioned as a specialized finance provider in the healthcare sector, focusing on companies with unique financial needs. Their competitive advantage lies in their expertise and tailored solutions.

Total Addressable Market (TAM)

The TAM for healthcare specialty finance is estimated to be in the billions. SWK Holdings Corp is positioned to capture a portion of this market through targeted lending and investment strategies.

Upturn SWOT Analysis

Strengths

  • Specialized expertise in healthcare finance
  • Customized financing solutions
  • Experienced management team
  • Strong portfolio of investments

Weaknesses

  • Concentration in the healthcare sector
  • Reliance on economic conditions affecting healthcare companies
  • Small cap status

Opportunities

  • Expansion into new healthcare verticals
  • Strategic partnerships with healthcare organizations
  • Increased demand for specialized healthcare finance

Threats

  • Changes in healthcare regulations
  • Increased competition from other finance providers
  • Economic downturn affecting healthcare investments

Competitors and Market Share

competitor logo Key Competitors

  • OXSQ
  • AINV
  • ARCC

Competitive Landscape

SWK Holdings Corp competes with other specialty finance firms in the healthcare sector. Their competitive advantage lies in their expertise, tailored solutions, and focus on specific healthcare verticals.

Major Acquisitions

Enteris BioPharma

  • Year: 2019
  • Acquisition Price (USD millions): 47.5
  • Strategic Rationale: Acquisition of royalty rights which are now managed by SWK's royalty monetization investment portfolio.

Growth Trajectory and Initiatives

Historical Growth: SWK Holdings Corp's historical growth can be assessed by examining its revenue and earnings growth over the past few years.

Future Projections: Future growth projections can be obtained from analyst estimates available on financial websites.

Recent Initiatives: Recent initiatives may include new investment strategies, partnerships, or expansions into new markets.

Summary

SWK Holdings is a niche player in healthcare finance with specialized expertise. The company's tailored financing solutions provide a competitive edge. Success depends on navigating healthcare regulations and adapting to market conditions. Growing competition and economic factors affecting healthcare are threats to watch.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Yahoo Finance
  • Bloomberg

Disclaimers:

This analysis is based on available information and should not be considered investment advice. Financial data and market conditions are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About SWK Holdings Corp

Exchange NASDAQ
Headquaters Dallas, TX, United States
IPO Launch date 1999-09-22
CEO & President Mr. Jody. D Staggs
Sector Financial Services
Industry Asset Management
Full time employees 29
Full time employees 29

SWK Holdings Corporation is a venture debt firm specializing in early stage, seed/startup, series-A to series-D and growth capital investments. It seeks to invest in healthcare sectors including biopharma, medical devices, diagnostics, life science tools, selective healthcare service and HIT companies; technology; software; SaaS; and green energy/sustainability. It seeks to make investments between $5 million and $20 million, it may also invest higher. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.